Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)

Sirion Therapeutics

Status and phase: Completed; Phase 3

Conditions: Dry Eye Syndromes

Treatments: Drug: cyclosporine

Study type: Interventional

Funder types: Industry

Identifiers

NCT00548301

ST-603-007

Details and patient eligibility

About

The purpose of this phase 3 study is to determine the safety and efficacy of cyclosporine in the treatment of dry eye syndrome.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of moderate to severe dry eye syndrome with or without Sjogren's syndrome or other autoimmune disease

Exclusion criteria

• Intraocular or refractive surgery in the study eye within 3 months prior to study start
• Unwilling to discontinue use of contact lenses during the run-in and duration of the study
• Pregnancy or lactation